The Uncomfortable Truth: Pros and Cons of AI in Healthcare, and Why Pharma’s Talent Crisis Matters
85% of pharma leaders want AI scale-up — but almost none have the talent required to make it safe.
December 12, 2025
85% of pharma leaders want AI scale-up — but almost none have the talent required to make it safe.
Most pharma teams are still trying to force AI into 20‑year‑old GxP processes — but the playbook they need already exists, and it didn’t come from EMA or FDA.
A pharma VP told me the moment everything changed: ‘We thought we knew our customers—until our data finally started talking to each other.’ What happened next shocked the entire team…
70% of pharma AI pilots skip formal governance—and leaders are shocked when audits hit
The biggest shock in clinical research this year? Smaller trials are winning—and the data is proving it.
The most expensive GMP error I ever saw? It wasn’t caused by equipment… it was caused by a training task someone thought had been completed.